Piramal Pharma Ltd (PPLPHARMA) — Announcement | 3 September 2026

3 September 2026 · BSE 🔴 High Importance Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

Piramal Pharma receives ESG rating of 65 from NSE Sustainability

💡 Investor Takeaway

The ESG rating improvement signals stronger sustainability practices, which may enhance long-term investor confidence.

Piramal Pharma disclosed that NSE Sustainability Ratings and Analytics assigned an ESG rating of 65 for FY 2025-26, up from 64, reflecting improved sustainability performance. The rating was prepared voluntarily by NSE Sustainability using publicly available data, without prior engagement, and is now posted on the company website for investor reference.

📄 View Original Announcement (PDF)

📊 Stock Analysis — PPLPHARMA ✨ Ask AI About This

About Piramal Pharma Ltd (PPLPHARMA)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹27,485.68 CrROE: -3.8%ROCE: 1.7%

View full PPLPHARMA stock details →

📡 Get AI alerts when PPLPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track PPLPHARMA — Free

💡 Ask AI about this filing

"How does this ESG rating compare to peers in the pharma sector?""What specific initiatives contributed to the rating improvement?""Will the company pursue third-party verification of its ESG performance?"

Ask AI Free →

📊 More PPLPHARMA filings

Announcement — 29 September 2026Piramal Pharma announced that its trading window will close on October 1, 2026, and remain shut for ...
🔴 Corporate Action — 29 September 2026Piramal Pharma disclosed a GST audit order requiring Rs. 4,06,03,220 in input tax credit demand and ...
🔴 Announcement — 18 September 2026Piramal Pharma disclosed that an independent ESG rating agency, Niche99, assigned it an ESG score of...
🔴 Announcement — 14 September 2026Piramal Pharma disclosed that the US FDA conducted a GMP inspection at its Morpeth, UK facility from...
🔴 Announcement — 8 September 2026Piramal Pharma announced its schedule for upcoming institutional investor meetings in late September...

See all PPLPHARMA filings →

🔥 Also filed on 3 September 2026

517554NHC Foods LtdAnnual Report HINDCOMPOSHindustan Composites LtdAnnouncement 534796JUJHAR LOGISTICS LIMITEDAnnual Report 500388Shree Krishna Paper Mills & Industries LtdAnnual Report VSTLVibhor Steel Tubes LtdInsider Trading GAUDIUMIVFGaudium IVF and Women Health LtdAnnual Report

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when PPLPHARMA files new disclosures

Track PPLPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.